| | GLA, RPL36A-HNRNPH2 (L429fs) | Deletion (frameshift variant +2 more) | Cardiovascular phenotype | |
| | GLA, RPL36A-HNRNPH2 (M421V) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +2 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (N419D) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +3 more | |
| | GLA, RPL36A-HNRNPH2 (V413A +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype | |
| | GLA, RPL36A-HNRNPH2 (R404fs) | Duplication (frameshift variant +2 more) | Cardiovascular phenotype | |
| | | Single nucleotide variant (synonymous variant +2 more) | GLA-related condition +3 more | |
| | GLA, RPL36A-HNRNPH2 (L394P) | Single nucleotide variant (missense variant +2 more) | not provided +2 more | |
| | GLA, RPL36A-HNRNPH2 (T385A) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +2 more | |
| | GLA, RPL36A-HNRNPH2 (A368T) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +2 more) | Fabry disease +1 more | GConflicting classifications of pathogenicity |
| | RPL36A-HNRNPH2, GLA (Y365N) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +3 more | |
| | GLA, RPL36A-HNRNPH2 (G360fs) | Deletion (frameshift variant +2 more) | Cardiovascular phenotype | |
| | GLA, RPL36A-HNRNPH2 (R356Q) | Single nucleotide variant (missense variant +2 more) | Fabry disease +3 more | GConflicting classifications of pathogenicity |
| | RPL36A-HNRNPH2, GLA (M353I +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype | |
| | GLA, RPL36A-HNRNPH2 (W349S) | Single nucleotide variant (missense variant +2 more) | Fabry disease +2 more | |
| | GLA, RPL36A-HNRNPH2 (E341A +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype | |
| | | Single nucleotide variant (synonymous variant +2 more) | Cardiovascular phenotype +2 more | |
| | GLA, RPL36A-HNRNPH2 (R332E) | Indel (missense variant +2 more) | Cardiovascular phenotype +3 more | |
| | GLA, RPL36A-HNRNPH2 (L331F) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +2 more) | not specified +2 more | |
| | | Single nucleotide variant (synonymous variant +2 more) | Cardiovascular phenotype +3 more | |
| | GLA, RPL36A-HNRNPH2 (Q321R) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +1 more | GPathogenic/Likely pathogenic |
| | GLA, RPL36A-HNRNPH2 (V316A) | Single nucleotide variant (missense variant +2 more) | Fabry disease +1 more | |
| | | Single nucleotide variant (synonymous variant +2 more) | GLA-related condition +4 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (D313N) | Single nucleotide variant (missense variant +2 more) | Fabry disease +2 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (D313Y) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +6 more | GConflicting classifications of pathogenicity; other |
| | GLA, RPL36A-HNRNPH2 (R301Q) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +3 more | |
| | GLA, RPL36A-HNRNPH2 (R301G) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +3 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (M290L) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +2 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (I289V) | Single nucleotide variant (missense variant +2 more) | not provided +3 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (W277G) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +2 more | |
| | GLA, RPL36A-HNRNPH2 (G271V) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +1 more | |
| | GLA, RPL36A-HNRNPH2 (D307H +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype | |
| | GLA, RPL36A-HNRNPH2 (R252T) | Single nucleotide variant (missense variant +2 more) | Fabry disease +2 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (I242V) | Single nucleotide variant (missense variant +2 more) | Fabry disease +2 more | |
| | | Single nucleotide variant (synonymous variant +2 more) | GLA-related condition +5 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (S238N) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +2 more | GPathogenic/Likely pathogenic |
| | GLA, RPL36A-HNRNPH2 (S235C) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +1 more | GPathogenic/Likely pathogenic |
| | GLA, RPL36A-HNRNPH2 (I232T) | Single nucleotide variant (missense variant +2 more) | Fabry disease +2 more | GPathogenic/Likely pathogenic |
| | GLA, RPL36A-HNRNPH2 (W226*) | Single nucleotide variant (nonsense +2 more) | Cardiovascular phenotype +1 more | |
| | GLA, RPL36A-HNRNPH2 (C223Y) | Single nucleotide variant (missense variant +2 more) | not provided +2 more | GPathogenic/Likely pathogenic |
| | GLA, RPL36A-HNRNPH2 (C223R) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +1 more | |
| | GLA, RPL36A-HNRNPH2 (Q221R +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype | |
| | GLA, RPL36A-HNRNPH2 (N215S) | Single nucleotide variant (missense variant +2 more) | Fabry disease +4 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Cardiovascular phenotype +4 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (M249I +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +1 more | |
| | | Single nucleotide variant (missense variant +2 more) | GLA-related condition +3 more | GConflicting classifications of pathogenicity |
| | RPL36A-HNRNPH2, GLA (L206F) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +2 more | |
| | GLA, RPL36A-HNRNPH2 (L206V) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +2 more | |
| | GLA, RPL36A-HNRNPH2 (P205T) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (synonymous variant +2 more) | Fabry disease +1 more | |
| | | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +2 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (N192Y) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype | |
| | GLA, RPL36A-HNRNPH2 (L189W) | Single nucleotide variant (missense variant +2 more) | Fabry disease +1 more | |
| | GLA, RPL36A-HNRNPH2 (G183S) | Single nucleotide variant (missense variant +2 more) | Fabry disease +2 more | |
| | GLA, RPL36A-HNRNPH2 (L180F +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype | |
| | GLA, RPL36A-HNRNPH2 (L180F) | Single nucleotide variant (missense variant +2 more) | Fabry disease +1 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (D175E) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +1 more | |
| | GLA, RPL36A-HNRNPH2 (D175E) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +3 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (G212D +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +1 more | |
| | GLA, RPL36A-HNRNPH2 (V164A +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype | |
| | RPL36A-HNRNPH2, GLA (D161N) | Single nucleotide variant (missense variant +2 more) | Fabry disease +1 more | |
| | GLA, RPL36A-HNRNPH2 (F159Y +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype | |
| | GLA, RPL36A-HNRNPH2 (F159L) | Single nucleotide variant (missense variant +2 more) | Fabry disease +1 more | |
| | GLA, RPL36A-HNRNPH2 (Q157*) | Single nucleotide variant (nonsense +2 more) | Cardiovascular phenotype +2 more | |
| | GLA, RPL36A-HNRNPH2 (S148R) | Single nucleotide variant (missense variant +2 more) | Fabry disease +1 more | GPathogenic/Likely pathogenic |
| | GLA, RPL36A-HNRNPH2 (A143T) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +2 more) | Cardiovascular phenotype +1 more | |
| | GLA, RPL36A-HNRNPH2 (K140T) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +2 more | |
| | GLA, RPL36A-HNRNPH2 (N139S) | Single nucleotide variant (missense variant +2 more) | not specified +2 more | |
| | GLA, RPL36A-HNRNPH2 (Y175* +1 more) | Single nucleotide variant (nonsense +2 more) | Cardiovascular phenotype | |
| | | Single nucleotide variant (synonymous variant +2 more) | Cardiovascular phenotype +1 more | |
| | GLA, RPL36A-HNRNPH2 (S126G) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Cardiovascular phenotype +1 more | |
| | | Single nucleotide variant (intron variant) | Cardiovascular phenotype +1 more | |
| | GLA, RPL36A-HNRNPH2 (R118C) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +4 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (H115P) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +1 more | |
| | GLA, RPL36A-HNRNPH2 (F113L) | Single nucleotide variant (missense variant +2 more) | Fabry disease +2 more | |
| | GLA, HNRNPH2 +1 more (R112H) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +2 more | |
| | | Single nucleotide variant (synonymous variant +2 more) | Cardiovascular phenotype +1 more | |
| | GLA, RPL36A-HNRNPH2 (L106P +1 more) | Single nucleotide variant (missense variant +2 more) | Fabry disease +1 more | |
| | GLA, RPL36A-HNRNPH2 (R105G) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +1 more | |
| | GLA, RPL36A-HNRNPH2 (Q99fs) | Duplication (frameshift variant +2 more) | Cardiovascular phenotype +2 more | |
| | GLA, RPL36A-HNRNPH2 (Q99*) | Single nucleotide variant (nonsense +2 more) | Fabry disease +1 more | |
| | GLA, RPL36A-HNRNPH2 (G85D) | Single nucleotide variant (missense variant +2 more) | Fabry disease +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (synonymous variant +2 more) | Cardiovascular phenotype +1 more | |
| | GLA, RPL36A-HNRNPH2 (D83N) | Single nucleotide variant (missense variant +2 more) | Fabry disease +2 more | GConflicting classifications of pathogenicity |
| | RPL36A-HNRNPH2, GLA (G80D) | Single nucleotide variant (missense variant +2 more) | not provided +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +2 more) | Cardiovascular phenotype +1 more | |
| | GLA, RPL36A-HNRNPH2 (L68F) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +1 more | GPathogenic/Likely pathogenic |
| | RPL36A-HNRNPH2, GLA (E66Q) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +2 more) | Fabry disease +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +2 more) | Cardiovascular phenotype +2 more | |
| | | Single nucleotide variant (synonymous variant +2 more) | Cardiovascular phenotype +3 more | |
| | | Single nucleotide variant (synonymous variant +2 more) | Fabry disease +4 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (T41S) | Single nucleotide variant (missense variant +2 more) | Fabry disease +2 more | |
| | | Single nucleotide variant (synonymous variant +2 more) | Cardiovascular phenotype | |
| | GLA, RPL36A-HNRNPH2 (P27fs) | Deletion (frameshift variant +2 more) | Cardiovascular phenotype +2 more | |
| | GLA, RPL36A-HNRNPH2 (D25V) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype | |